Meridian Medical Inc.-Provides Educational Grant for Curves Study by Dr. James A. McHale.

VANCOUVER, British Columbia -- Meridian Co., Ltd. ("Meridian") (OTCBB: MRDAF), is pleased to announce that its subsidiary, Meridian Medical Inc. ("MMI" or "the Company") has provided an educational grant to Dr. James A. McHale, a renowned clinician and researcher with over 10 years' experience.

Dr. McHale has extensive experience with medical diagnostic testing. To date he has conducted over 8,000 diagnostic tests from bone density to metabolic tests within 45 Curves for Women ("Curves") locations.

The grant the Company has provided is for a clinical research study using the Digital Pulse Analyzer ("DPA") to test members of Curves. The tests will measure the effects of exercise and diet and cardiovascular and circulatory improvement on Curves participants. The Company feels fortunate to have Curves use our product for clinical research as Curves has over 5,000 fitness centers and over one million members in the United States.

The research study is based on a test group of approximately 28 participants over a 45-day period using the Curves exercise and diet program. The study is in its second phase and is expected to be complete the final study by September 14, 2004.

The first phase of Dr. McHale's study with the DPA has shown a 48% improvement over a 45-day period to date. This translates into an average of 8.9 years of improvement in total cardiovascular heath and life span potential if the program is adhered to.

More about: Digital Pulse Analyzer ("DPA")

The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion

ABOUT MERIDIAN

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of it's products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.